add share buttonsSoftshare button powered by web designing, website development company in India

FDA Recall Of Ranitidine

In September 2019, the U.S. Food and Drug Administration warned about impurities in Zantac, a brand-name drug. These impurities could cause cancer in humans. The impurity is called N-nitrosodimethylamine (NDMA). Based on laboratory tests, NDMA has been identified as an environmental contaminant. It is a probable cause of cancer in humans. 

Exposure to high levels of NDMA over a prolonged period of time may lead to cancer. Some foods, such as vegetables, meats, and dairy products, contain NDMA. People and their families who have been treated for heartburn with Zantac or generic Zantac as well as Nexium, Prilosec, Prilosec, and Prevacid may be eligible to file a lawsuit against the drug. To find out if you are eligible or not 'browse around here' to have words with lawyers for your case.


Image Source: Google

When a laboratory informed the FDA of very high levels of NDMA found in ranitidine products, the FDA announced its findings. Multiple medical studies from the 1980s have provided evidence of the drug's risk. Sanford University performed urine tests on 10 patients who had taken Zantac 150 mg tablets. The results showed that NDMA levels were higher than the FDA's daily limit.

A California lab, recently reported that NDMA was being produced by ranitidine, a drug. Researchers stated that prolonged heat exposure during shipping or Zantac being left in a vehicle in summer can result in NDMA.

FDA asked drug companies producing ranitidine to test their products for NDMA. If lab tests showed that the ranitidine medication had NDMA levels exceeding the daily intake limit, the FDA advised drug companies to remove the product from the market. Ranitidine medication has been recalled by many manufacturers.